National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Review of Indacaterol (Onbrez®) for the treatment of COPD.

Rapid Review

Commenced Completed Outcome
15/01/2010 Full Pharmacoeconomic Evaluation not Recommended.

It is recommended that Indacaterol (Onbrez®) should not be subjected to a PEA at this time.